Clinician-Reported Impact of Germline Multigene Panel Testing on Cancer Risk Management Recommendations

BACKGROUND: With increased adoption of multi-gene panel testing (MGPT) for hereditary cancer, management guidelines now include a wider range of predisposition genes. Yet little is known about whether MGPT results prompt changes to clinicians’ risk management recommendations and whether those recomm...

Descripción completa

Detalles Bibliográficos
Autores principales: Horton, Carolyn, Blanco, Kirsten, Lo, Min-Tzu, Speare, Virginia, LaDuca, Holly, Dolinsky, Jill S, Kurian, Allison W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904928/
https://www.ncbi.nlm.nih.gov/pubmed/35603838
http://dx.doi.org/10.1093/jncics/pkac002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904928/
https://www.ncbi.nlm.nih.gov/pubmed/35603838
http://dx.doi.org/10.1093/jncics/pkac002

Ejemplares similares